San Francisco
Pfizer will open the 105,000-sf Biotherapeutics and Bioinnovation Center (BBC) in San Francisco’s Mission Bay development in 2010. Located adjacent to the University of California, San Francisco's Quantitative Biosciences (QB3) research facility, the leased five-story building will enable Pfizer to pursue collaborative research with academic and industry partners. The project developer is Alexandria Real Estate Equities. Pfizer may lease an additional 50,000-sf in another wing of the building. Construction of the drug discovery facility commenced in summer of 2008.
